Table 1 Clinical properties of cutaneous melanoma patients in OSskcm
GEO ID | References | Platform | No. of samples | Death event | Median overall survival (months) | Ages (years) | Gender (male/female) | Primary/metastatic | Stage (I/II/III/IV) |
|---|---|---|---|---|---|---|---|---|---|
GSE17275 | [20] | GPL1930 | 60 | 41 | 64.00 (46.25–89.50) | NA | NA | 20/40 | 2/8/19/31 |
GSE22155 | [21] | GPL6102 GPL6947 | 70 | 60 | 7.27 (2.10–13.80) | 56.63 ± 14.58 | 39/31 | 0/70 | 0/0/3/67 |
GSE46517 | [22] | GPL96 | 84 | 40 | 71 (55–89)a | 77.03 ± 26.37 | 39/24c | 31/53 | 12/15/11/24 |
GSE50509 | [23] | GPL10558 | 19 | 15 | 18.11 (8.63–26.53) | 57.68 ± 15.49 | 12/7 | 0/19 | NA |
GSE65904 | [24] | GPL10558 | 214 | 102 | 17.80 (7.03–41.83)b | 62.35 ± 14.40 | 124/89‡ | 16/188‡ | NA |
GSE98394 | [25] | GPL16791 | 51 | 18 | 93.50 (35.00–111.00) | NA | 31/20 | 51/0 | 12/22/10/0‡ |
GSE19234 | [26] | GPL570 | 38 | 24 | 38.08 (23.57–65.90) | 62.66 ± 17.86 | 24/14 | 0/38 | 0/0/34/4 |
GSE53118 | [27] | GPL6884 | 79 | 47 | 79.74 (28.81–120.05) | 55.49 ± 15.27 | 50/29 | 0/79 | 0/0/79/0 |
TCGA | [28] | Illumina HiSeqV2 | 470 | 216 | 34.45 (14.90–75.17) | 58.22 ± 15.73 | 290/180 | 103/364‡ | 77/140/171/23‡ |
Total |  |  | 1085 | 563 | 39.30 (15.92–88.00) | 59.14 ± 15.55 | 609/394 | 221/851 | 131/215/268/149 |